Notice of Issuance of Regulatory Guide, 42377 [E8-16577]

Download as PDF Federal Register / Vol. 73, No. 140 / Monday, July 21, 2008 / Notices PWALKER on PROD1PC71 with NOTICES addresses, or home phone numbers in their filings. With respect to copyrighted works, except for limited excerpts that serve the purpose of the adjudicatory filings and would constitute a Fair Use application, Participants are requested not to include copyrighted materials in their submissions. The Commission will issue a notice or order granting or denying a hearing request or intervention petition, designating the issues for any hearing that will be held and designating the Presiding Officer. A notice granting a hearing will be published in the Federal Register and served on the parties to the hearing. Within 30 days from the date of publication of this notice, persons may submit written comments regarding the license transfer application, as provided for in 10 CFR 2.1305. The Commission will consider and, if appropriate, respond to these comments, but such comments will not otherwise constitute part of the decisional record. Comments should be submitted to the Secretary, U.S. Nuclear Regulatory Commission, Washington, DC 20555–0001, Attention: Rulemakings and Adjudications Staff, and should cite the publication date and page number of this Federal Register notice. For further details with respect to this license transfer application, see the application dated December 20, 2007, available for public inspection at the Commission’s Public Document Room (PDR), located at One White Flint North, Public File Area O1 F21, 11555 Rockville Pike (first floor), Rockville, Maryland. Publicly available records will be accessible electronically from the Agencywide Documents Access and Management System’s (ADAMS) Public Electronic Reading Room on the Internet at the NRC Web site, https:// www.nrc.gov/reading-rm/adams.html. Persons who do not have access to ADAMS or who encounter problems in accessing the documents located in ADAMS should contact the NRC PDR Reference staff by telephone at 1–800– 397–4209, or 301–415–4737 or by e-mail to pdr@nrc.gov. Dated at Rockville, Maryland this 14th day of July 2008. For the Nuclear Regulatory Commission. John Stang, Senior Project Manager, Plant Licensing Branch II–1, Division of Operating Reactor Licensing, Office of Nuclear Reactor Regulation. [FR Doc. E8–16600 Filed 7–18–08; 8:45 am] BILLING CODE 7590–01–P VerDate Aug<31>2005 19:22 Jul 18, 2008 Jkt 214001 NUCLEAR REGULATORY COMMISSION Notice of Issuance of Regulatory Guide Nuclear Regulatory Commission. ACTION: Notice of Issuance and Availability of Regulatory Guide 6.2, Revision 2 AGENCY: FOR FURTHER INFORMATION CONTACT: Mark Orr, Regulatory Guide Development Branch, Division of Engineering, Office of Nuclear Regulatory Research, U.S. Nuclear Regulatory Commission, Washington, DC 20555–0001, telephone (301) 415– 6373 or e-mail to Mark.Orr@nrc.gov. SUPPLEMENTARY INFORMATION: I. Introduction The U.S. Nuclear Regulatory Commission (NRC) has issued revisions to existing guides in the agency’s ‘‘Regulatory Guide’’ series. This series was developed to describe and make available to the public information such as methods that are acceptable to the NRC staff for implementing specific parts of the agency’s regulations, techniques that the staff uses in evaluating specific problems or postulated accidents, and data that the staff needs in its review of applications for permits and licenses. Revision 2 of Regulatory Guide 6.2, ‘‘Integrity and Test Specifications for Selected Brachytherapy Sources,’’ was issued with a temporary identification as Draft Regulatory Guide DG–6004. This guide directs the reader to the type of information acceptable to the NRC staff to evaluate the integrity and test specifications for selected brachytherapy sources. The manufacture of brachytherapy sources containing byproduct material requires a license pursuant to Title 10, section 30.3, ‘‘Activities Requiring License,’’ of the Code of Federal Regulations (10 CFR 30.3). Brachytherapy sources manufactured under such a license must meet certain integrity requirements and pass certain tests. The regulation at 10 CFR 32.74(a)(2)(iii) requires that an application for a specific license to manufacture and distribute brachytherapy sources and devices containing byproduct material include a description of the procedures for, and results of, prototype tests performed to demonstrate that the source or device will maintain its integrity under stresses likely to be encountered in normal use and accidents. Additionally, 10 CFR 32.74(a)(2)(v) requires that the application also include details of quality control procedures to ensure PO 00000 Frm 00065 Fmt 4703 Sfmt 4703 42377 that production sources and devices meet the standards of the design and prototype tests. This regulatory guide endorses the methods and procedures for integrity and test specifications of selected brachytherapy sources contained in the current revisions of NUREG–1556, Volume 3, ‘‘Consolidated Guidance about Materials Licenses: Applications for Sealed Source and Device Evaluation and Registration’’ and NUREG–1556, Volume 9, ‘‘Consolidated Guidance about Materials Licenses: ProgramSpecific Guidance about Medical Use Licenses’’ as a process that the NRC staff has found to be acceptable for meeting the regulatory requirements. II. Further Information In December 2007, DG–6004 was published with a public comment period of 60 days from the issuance of the guide. No comments were received and the public comment period closed on April 18, 2008. Electronic copies of Regulatory Guide 6.2, Revision 2 are available through the NRC(s public Web site under ‘‘Regulatory Guides’’ at https://www.nrc.gov/reading-rm/doccollections/. In addition, regulatory guides are available for inspection at the NRC’s Public Document Room (PDR), which is located at Room O–1F21, One White Flint North, 11555 Rockville Pike, Rockville, Maryland 20852–2738. The PDR’s mailing address is USNRC PDR, Washington, DC 20555–0001. The PDR can also be reached by telephone at (301) 415–4737 or (800) 397–4209, by fax at (301) 415–3548, and by e-mail to pdr@nrc.gov. Regulatory guides are not copyrighted, and NRC approval is not required to reproduce them. Dated at Rockville, Maryland, this 11th day of July, 2008. For the Nuclear Regulatory Commission. Stephen C. O’Connor, Acting Chief, Regulatory Guide Development Branch, Division of Engineering, Office of Nuclear Regulatory Research. [FR Doc. E8–16577 Filed 7–18–08; 8:45 am] BILLING CODE 7590–01–P NUCLEAR REGULATORY COMMISSION [Docket No. 50–281] Virginia Electric and Power Company, et al., Surry Power Station, Unit No. 2 Notice of Issuance of Amendment to Facility Operating License; Correction Nuclear Regulatory Commission. AGENCY: E:\FR\FM\21JYN1.SGM 21JYN1

Agencies

[Federal Register Volume 73, Number 140 (Monday, July 21, 2008)]
[Notices]
[Page 42377]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-16577]


-----------------------------------------------------------------------

NUCLEAR REGULATORY COMMISSION


Notice of Issuance of Regulatory Guide

AGENCY: Nuclear Regulatory Commission.

ACTION: Notice of Issuance and Availability of Regulatory Guide 6.2, 
Revision 2

-----------------------------------------------------------------------

FOR FURTHER INFORMATION CONTACT: Mark Orr, Regulatory Guide Development 
Branch, Division of Engineering, Office of Nuclear Regulatory Research, 
U.S. Nuclear Regulatory Commission, Washington, DC 20555-0001, 
telephone (301) 415-6373 or e-mail to Mark.Orr@nrc.gov.

SUPPLEMENTARY INFORMATION:

I. Introduction

    The U.S. Nuclear Regulatory Commission (NRC) has issued revisions 
to existing guides in the agency's ``Regulatory Guide'' series. This 
series was developed to describe and make available to the public 
information such as methods that are acceptable to the NRC staff for 
implementing specific parts of the agency's regulations, techniques 
that the staff uses in evaluating specific problems or postulated 
accidents, and data that the staff needs in its review of applications 
for permits and licenses.
    Revision 2 of Regulatory Guide 6.2, ``Integrity and Test 
Specifications for Selected Brachytherapy Sources,'' was issued with a 
temporary identification as Draft Regulatory Guide DG-6004. This guide 
directs the reader to the type of information acceptable to the NRC 
staff to evaluate the integrity and test specifications for selected 
brachytherapy sources. The manufacture of brachytherapy sources 
containing byproduct material requires a license pursuant to Title 10, 
section 30.3, ``Activities Requiring License,'' of the Code of Federal 
Regulations (10 CFR 30.3). Brachytherapy sources manufactured under 
such a license must meet certain integrity requirements and pass 
certain tests. The regulation at 10 CFR 32.74(a)(2)(iii) requires that 
an application for a specific license to manufacture and distribute 
brachytherapy sources and devices containing byproduct material include 
a description of the procedures for, and results of, prototype tests 
performed to demonstrate that the source or device will maintain its 
integrity under stresses likely to be encountered in normal use and 
accidents. Additionally, 10 CFR 32.74(a)(2)(v) requires that the 
application also include details of quality control procedures to 
ensure that production sources and devices meet the standards of the 
design and prototype tests.
    This regulatory guide endorses the methods and procedures for 
integrity and test specifications of selected brachytherapy sources 
contained in the current revisions of NUREG-1556, Volume 3, 
``Consolidated Guidance about Materials Licenses: Applications for 
Sealed Source and Device Evaluation and Registration'' and NUREG-1556, 
Volume 9, ``Consolidated Guidance about Materials Licenses: Program-
Specific Guidance about Medical Use Licenses'' as a process that the 
NRC staff has found to be acceptable for meeting the regulatory 
requirements.

II. Further Information

    In December 2007, DG-6004 was published with a public comment 
period of 60 days from the issuance of the guide. No comments were 
received and the public comment period closed on April 18, 2008. 
Electronic copies of Regulatory Guide 6.2, Revision 2 are available 
through the NRC(s public Web site under ``Regulatory Guides'' at http:/
/www.nrc.gov/reading-rm/doc-collections/.
    In addition, regulatory guides are available for inspection at the 
NRC's Public Document Room (PDR), which is located at Room O-1F21, One 
White Flint North, 11555 Rockville Pike, Rockville, Maryland 20852-
2738. The PDR's mailing address is USNRC PDR, Washington, DC 20555-
0001. The PDR can also be reached by telephone at (301) 415-4737 or 
(800) 397-4209, by fax at (301) 415-3548, and by e-mail to pdr@nrc.gov.
    Regulatory guides are not copyrighted, and NRC approval is not 
required to reproduce them.

    Dated at Rockville, Maryland, this 11th day of July, 2008.

    For the Nuclear Regulatory Commission.
Stephen C. O'Connor,
Acting Chief, Regulatory Guide Development Branch, Division of 
Engineering, Office of Nuclear Regulatory Research.
[FR Doc. E8-16577 Filed 7-18-08; 8:45 am]
BILLING CODE 7590-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.